Timber Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
Other companies in the scoring peer group for Timber Pharmaceuticals Inc are shown below. Browse to the end of this webpage for potential risks for Timber Pharmaceuticals Inc based on industry, location and size. The page is a zero-cost E,S&G assessment covering Timber Pharmaceuticals Inc.
Timber Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.9; made up of an environmental score of 4.0, social score of 2.7 and governance score of 8.0.
4.9
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 744 | Sopharma AD | 5.0 | High |
| 744 | vTv Therapeutics Inc | 5.0 | High |
| 764 | Timber Pharmaceuticals Inc | 4.9 | High |
| 764 | BetterLife Pharma Inc | 4.9 | High |
| 764 | Acerus Pharmaceuticals Corporation | 4.9 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Timber Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Timber Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Timber Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Timber Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Timber Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Timber Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Timber Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Timber Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to severe subtypes of CI, a group of rare genetic keratinization disorders; and TMB-002, a proprietary topical formulation of rapamycin, which is in Phase 2b clinical trial for the treatment of facial angiofibroma in tuberous sclerosis complex, a multisystem genetic disorder resulting in the growth of hamartomas in multiple organs. It is also involved in the development of TMB-003, a proprietary formulation of Sitaxsentan, which is a selective endothelin-A receptor antagonist that is in preclinical development for the treatment of sclerotic skin diseases. In addition, the company engages in the development of BPX-01, which is in Phase 3 topical minocycline for the treatment of inflammatory lesions of acne vulgaris; and BPX-04 that is a Phase 3 ready topical minocycline for the treatment of papulopustular rosacea. It has license agreement with AFT Pharmaceuticals Limited. The company was founded in 2019 and is headquartered in Basking Ridge, New Jersey.